Charles River Laboratories
Stacey Wright ACMA CGMA is a seasoned finance professional with extensive experience in fixed asset management and financial reporting. Currently serving as Fixed Asset Manager at Charles River Laboratories since September 2023, Stacey has held key positions such as Associate Director Business Performance Lead and Associate Director Client Accounting at CBRE from July 2019 to August 2023. Previous roles include Legal Entity Governance Manager at Morgan Stanley and Strategic Project Accountant at MITIE PROPERTY MANAGEMENT LIMITED. With a robust background at Shell spanning nearly two decades, Stacey's roles included Financial Accountant, Data Process Design Analyst, Financial Process Expert, and Fixed Assets Team Manager, where significant process improvements and team leadership were demonstrated. Educational credentials include a BA Honours from The Open University and a Diploma in Forensic Accounting from Brentwood Open Learning College.
This person is not in any teams
This person is not in any offices
Charles River Laboratories
16 followers
Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment includes Research Models and Research Model Services. The DSA segment includes Discovery Services and Safety Assessment. The Manufacturing segment includes Microbial Solutions, Avian, Biologics and Contract Manufacturing. The Company also provides a suite of products and services to support the Company's clients' manufacturing activities.